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summARy – different outcomes of brucellosis in pregnancy regarding the fetus/neonate and 
the mother are described. medical records of five pregnant women with brucellosis were retrospec-
tively analyzed. patients were treated in several departments of infectious diseases in the Republic of 
macedonia between 1995 and 2009. The diagnosis of brucellosis was based on clinical findings com-
patible with the disease supported by detection of specific antibodies. pregnancy outcomes in patients 
were as follows: spontaneous abortion, intrauterine fetal death, premature delivery in two cases (one 
with twin pregnancy) and term delivery. one of the women experienced relapse. follow-up results of 
neonates showed no infection and their normal growth and development. Brucellosis, especially if 
acquired in early pregnancy, can have an impact on pregnancy outcome. in endemic regions, in preg-
nant women with persisting fever and unspecific manifestations one should always have in mind 
brucellosis. in these areas, cases with unexplained spontaneous abortion, intrauterine fetal death and 
premature delivery should also be investigated for brucellosis.
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Introduction
Brucellosis is a zoonosis, which is mainly acquired 
through contact with infected animals or their prod-
ucts, or by consumption of improperly cooked food 
of animal origin1. in line with this notion, brucellosis 
is most commonly an endemic or professionally ac-
quired disease. it affects all age groups of both gen- 
ders, including pregnant women. Brucellosis is rare in 
pregnancy2, with an incidence in endemic areas from 
1.3% to 12.2%3-5. in other words, in these regions, 
1.5% to 17% of cases with brucellosis are pregnant 
women4,6-8.
unlike animal brucellosis, which is mainly charac-
terized by affecting the genital system and conse-
quently resulting in abortions and sterility1,9, there is 
controversy regarding the relationship between human 
brucellosis and pregnancy outcome10. some authors 
think that pregnant women with brucellosis do not 
have a larger number of abortions than do those with 
other bacteremic infections11-13. These attitudes are 
based on the fact that, unlike animal placenta, human 
placenta has no, or has low amounts of erythrol, as well 
as the presence of anti-brucellar activity in human am-
niotic fluid3,5,8,14. on the other hand, there are reports 
that brucellosis in pregnant women, especially when 
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Brucella melitensis is the causative agent, may lead to an 
increased rate of spontaneous abortion, intrauterine 
fetal death (iufd) , and premature delivery. The main 
reasons for adverse obstetric outcome may be attrib-
uted to maternal bacteremia, endotoxemia, acute fe-
brile reaction, disseminated intravascular coagulation, 
placentitis4,5,7,8,15-17, or even allergic mechanism in 
chronic brucellosis7. The possible complications in 
brucellosis during pregnancy should also be consid-
ered, e.g., low birth weight2,18, neonatal infection5,19-22, 
maternal and neonatal death18, and even transmission 
of the disease from patients to medical personnel23,24. 
Brucellosis during pregnancy has not been shown to 
be associated with congenital anomalies2,24,25, although 
there are communications reporting contrary results18. 
our aim was to present different outcomes of brucel-
losis in pregnancy.
Methods
we retrospectively analyzed medical records of five 
pregnant women with brucellosis that were treated in 
the departments of infectious diseases in the Republic 
of macedonia between 1995 and 2009. The study was 
approved by the local institutional Review Boards in 
compliance with the principles of the declaration of 
helsinki and its later amendments. All patients gave 
their written consent for publishing their medical doc-
umentation by preserving their anonymity.
The diagnosis of brucellosis was based on clinical 
findings compatible with the disease supported by de-
tection of specific antibodies, Rose Bengal and either 
standard tube agglutination test (stA) plus Brucella 
Coombs test or Brucellacapt test at significant titers, as 
previously described26,27.
none of the presented patients had a prior history 
of brucellosis, chronic venereal diseases, pathologic 
pregnancies or abortions. At admission, all patients 
underwent routine hematologic and biochemical tests 
including hemoglobin (hb), red blood cell (RBC) 
count, white blood cell (wBC) count, neutrophils 
(ne), platelet (pt) count, alanine aminotransferase/as-
partate aminotransferase (Alt/Ast), creatinine, 
erythrocyte sedimentation rate (esR), C-reactive pro-
tein (CRp) and urine culture. patients were managed 
by an interdisciplinary team including infectious dis-
ease and obstetric specialists. Their babies were man-




A 25-year-old patient, teacher, mother of one 
healthy child. This was her second pregnancy in the 
11th gestational week. The patient had been ill for two 
weeks until the diagnosis of brucellosis was made; she 
had back pain, malaise, sweating, headache and tem-
perature of 38.4 oC. she acquired the disease through 
consumption of soft sheep cheese. At admission, wrist 
arthritis was recorded. gynecologic examination was 
unremarkable. laboratory analyses showed the fol-
lowing results: hb 120 g/l, RBC 4100x1012/l, wBC 
4.6x109/l, ne 62%, pl 200x1012/l, Alt/Ast 22/18 
u/l, creatinine 64 µmol/l, esR 60 mm/h, CRp 64 
mg/l, urine culture negative, Rose Bengal positive, 
stA 1/1280, Brucella Coombs test 1/1280.
immediately after establishment of the diagnosis, 
treatment with rifampin plus cotrimoxazole was initi-
ated. in the first week of treatment, subfebrile tem-
peratures were recorded, with withdrawal of wrist ar-
thritis on day 6 of treatment. two weeks from the be-
ginning of treatment, i.e. in the 13th week of gestation, 
vaginal bleeding was recorded. hexoprenaline and 
isoptin were used to treat the condition, however, three 
days later, the pregnancy ended with spontaneous 
abortion. pathologic findings showed nonspecific in-
flammatory changes.
After the spontaneous abortion, doxycycline was 
added to the combination of rifampin and cotrimoxa-
zole for the next 4 weeks. Three weeks after this treat-
ment had been completed relapse was recorded and 
the patient was re-treated with the same regimen for 
45 days. during 36 months of follow-up, the disease 
outcome was favorable.
Case 2
A 28-year-old patient, housewife, mother of three 
healthy children. when brucellosis was diagnosed, she 
was in the 10th week of pregnancy. The patient was en-
gaged in processing raw milk as part of a family busi-
ness of sheep breeding. several family members had 
previously suffered from brucellosis. her illness began 
six weeks prior to admission, with temperature of 39 
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oC, fever, malaise, arthralgias, sweating. gynecologic 
examination at admission was otherwise unremarkable 
with the following laboratory results: hb 136 g/l, 
RBC 4490x1012/l, wBC 4,0x109/l, ne 58%, pl 
251x1012/l, Alt/Ast 28/22 u/l, creatinine 96 
µmol/l, esR 20 mm/h, CRp 24 mg/l, urine culture 
negative, Rose Bengal positive, stA 1/320 Coombs 
1/1280.
The patient was treated with rifampin plus cotri-
moxazole for 45 days. defervescence was achieved on 
the second day of therapy introduction. during the 
treatment, the patient had regular gynecologic controls 
with normal findings. in the 28th week of pregnancy (3 
months after antibrucellar treatment had been fin-
ished) the mother noticed absence of fetal movements. 
ultrasound revealed intrauterine fetal death and a 
dead baby weighing 2100 g was delivered by provoked 
contractions. Autopsy was not made. microbiological 
examinations showed that some infectious agents 
(Toxoplasma, Rubella, Cytomegalovirus, Treponema, 
Chlamydia, Ureaplasma, Herpes simplex) were not the 
cause of iufd. during one year follow-up period, no 
relapses were recorded.
Case 3
A housewife, at the age of 20 years, first pregnancy, 
30 weeks of gestation. Brucellosis was acquired 
through direct contact with infected sheep and goats; 
other family members had brucellosis at the same 
time. The disease began two months prior to admis-
sion to the hospital, and predominant symptoms were 
malaise, pains in the right hip, temperature of 39 oC, 
night sweats, reduced appetite, and headache. gyneco-
logic examination at admission was normal and the 
findings of laboratory analyses were as follows: hb 92 
g/l, RBC 3430x1012/l, wBC 14.0x109/l, ne 64%, pl 
278x1012/l, ne 52%, Alt/Ast 12/16 u/l, creati-
nine 75 µmol/l, esR 90 mm/h, CRp 84 mg/l, urine 
culture negative, Rose Bengal positive, Brucellacapt 
1/5120.
treatment with rifampin plus cotrimoxazole was 
initiated. defervescence was achieved on the third day. 
fourteen days after the treatment had been initiated 
(32nd gestational week) the mother delivered sponta-
neously a baby boy weighing 2350 g with Apgar score 
7/8. serologic testing of the baby showed negative 
Rose Bengal and Brucellacapt 1/80. The baby was for-
mula-fed, and his postnatal development was normal. 
The treatment of the mother in the course of the next 
4 weeks after delivery continued with rifampin plus 
cotrimoxazole plus doxycycline.
The mother was followed-up for 19 months; she 
had no problems; the baby was followed-up for 1 year; 
he had normal development without any symptoms/
signs and negative Brucellacapt at the end of the first 
year.
Case 4
A 27-year-old patient, administrative employee, 
her first twin pregnancy; brucellosis was diagnosed in 
her 20th gestational week. The patient suffered from ex-
cessive sweating, malaise, headache, reduced appetite, 
arthralgias, nausea, and vomiting for 3 weeks. her 
pregnancy was regularly controlled and it was without 
any problems. There were no data for contacts with in-
fected animals or convincing indicators that the dis-
ease had been acquired by ingestion of suspicious food. 
At admission laboratory results were as follows: hb 
109 g/l, RBC 3450x1012/l, wBC 9.3x109/l, ne 
80%, pl 283x1012/l, Alt/Ast 124/68 u/l, creati-
nine 84 µmol/l, esR 100 mm/h CRp 46 mg/l, Rose 
Bengal positive, Brucellacapt 1/2560.
The patient was treated with rifampin plus cotri-
moxazole for 45 days. she was regularly followed-up 
by infectious diseases and gynecology specialists. Ce-
sarean section was performed at 32nd week of pregnan-
cy, six weeks after completion of the antibrucellar 
treatment. she had a preterm delivery due to cardioto-
cographic signs of fetal distress. The surgical procedure 
proceeded without complications. Birth weight of the 
newborn male twins was 1290 and 1770 g, and Apgar 
score in both babies was 5/6/7. initial Rose Bengal was 
positive in the babies, and Brucellacapt test was 1/160 
and 1/80. The babies were in the incubator in the first 
3 weeks and were formula-fed.
psychophysical development of the babies was nor-
mal during one year follow-up, and Rose Bengal and 
Brucellacapt were negative at nine months of delivery. 
The course of brucellosis in the mother was satisfac-
tory, without relapses.
Case 5
A 29-year-old patient, housewife, mother of 3 
healthy children. Brucellosis was diagnosed at 30th 
week of gestation of her fourth pregnancy. she ac-
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quired the disease while processing milk and consum-
ing young cheese. her family was engaged in sheep 
breeding and several family members had been previ-
ously or were currently treated for brucellosis. The dis-
ease started three months prior to her admission, when 
she presented with temperature of 38.2 oC, sweating, 
malaise, headache, arthralgias and left hip arthritis. 
gynecologic examination at admission was unremark-
able, and laboratory analyses showed hb 87 g/l, RBC 
3250x1012/l, wBC 7.8x109/l, pl 263x1012/l, Alt/
Ast 54/68 u/l, creatinine 56 µmol/l, esR 50 mm/h, 
CRp 2 mg/l, urine culture negative, Rose Bengal pos-
itive, stA 1/320 Coombs 1/640.
The patient was treated with rifampin plus cotri-
moxazole for 45 days. defervescence was achieved on 
the fourth day after initiation of treatment, and periph-
eral arthritis withdrew 21 days later. spontaneous vagi-
nal delivery happened in the 39th gestational week, three 
weeks after antibrucellar treatment had been completed. 
Birth weight of the male newborn was 3100 g, and Ap-
gar score was 9/9. initial serologic values in the newborn 
were positive Rose Bengal, stA 1/20 and Brucella 
Coombs test 1/40. The baby was breastfed.
The baby presented with positive results of sero-
logic tests in the first 6 months, after which they were 
negative. Throughout the follow-up period, the baby 
was in good general condition and with normal growth 
and development. The mother was followed-up for 6 
months and no relapses were noticed.
Discussion
we have presented different outcomes in pregnan-
cy as a result of human brucellosis. The reported inci-
dence of spontaneous abortions, iufd and preterm 
delivery during brucellosis ranges from 2.5%2 to 53%4, 
2%8 to 13%5 and 3%8 to 29%10. however, there are 
many studies that report term delivery as final out-
come of pregnancy4,5,25,28,29.
Three of the patients presented (cases 2, 3 and 5) 
were exposed to direct contact with infected animals 
or their products as a source of acquiring the disease 
and at the same time brucellosis was found in several 
family members. These data have been presented in 
other studies, too7,30. A family history of brucellosis has 
been identified as a trait of brucellosis in endemic areas 
and reflects dietary habits and involvement in stock-
breeding31. it is also interesting that in two of our pa-
tients (cases 1 and 5), peripheral arthritis was mani-
fested, and it is the most frequent focal form of brucel-
losis in this endemic region31,32. Clinical presentation 
of brucellosis in our patients comprised manifestations 
that are unspecific and sometimes assigned to preg-
nancy itself, which might be a cause for delayed estab-
lishment of the diagnosis. nevertheless, elevated tem-
perature in pregnant women from endemic regions 
(which was found in four of our patients), has to arouse 
suspicion of brucellosis.
in cases 1 and 2, the disease was acquired early in 
pregnancy, which might be one of the causes of adverse 
outcome. A higher rate of spontaneous abortion in the 
first trimester was also noted by other authors5,18, while 
another group of authors report that abortion usually 
occurs in the second trimester8,33. fever and vaginal 
bleeding known as factors that influence fetal loss34 were 
present in our case 1, and although the treatment was 
started early, the outcome was poor. The cases presented 
in this study did not confirm the general notions that 
timely initiated treatment has positive impact (case 1) or 
that delayed treatment has adverse outcome of preg-
nancy (case 5). This might be due to the fact that we 
present isolated cases and not series of patients.
in the literature, there is controversy regarding the 
association of abortion with the magnitude of serology. 
According to some authors, the magnitude of serology 
in pregnant women is not associated with spontaneous 
abortions4,8, whereas others found higher incidence of 
abortion in cases with higher serology5-7. our patients 
with spontaneous abortion, iufd and prematurity 
(cases 1, 2, 3 and 4) had high initial serologic titers, 
whereas the patient with favorable pregnancy outcome 
(case 5) showed only moderately initially high titer.
in contrast to case 3, where preterm labor happened 
during the treatment, in case 4 preterm labor happened 
6 weeks after treatment completion and hence it is un-
clear whether brucellosis had an impact on preterm de-
livery. to our knowledge, our case of brucellosis during 
twin pregnancy with good outcome is the second case 
published in the literature35. iufd described in our pa-
tient (case 2) appeared 3 months after completion of 
antibrucellar treatment and good clinical course in the 
mother. in the absence of other infectious agents, iufd 
might be due to intrauterine brucellosis that had 
emerged in the very early pregnancy period.
positive low-value serologic titers found in the 
newborns (cases 3, 4 and 5) in the first months after 
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delivery were due to transplacental transmission of 
maternal antibodies7,25,36, and became negative during 
the follow-up period.
prompt treatment in pregnant women with brucel-
losis is paramount to decrease devastating outcomes8,18. 
it is known that the risk of abortions and preterm labor 
is increasing without appropriate therapy4,8,18. in all of 
our patients, the treatment concerning antimicrobial 
choice and duration was uniform, i.e. a combination of 
rifampin and cotrimoxazole for 45 days. A limited 
number of treatment options of brucellosis in pregnan-
cy is presented in the literature, having in mind that 
tetracyclines, quinolones, and very often aminoglyco-
sides are not recommended in this population. Beside 
monotherapy or combined therapy with rifampin10,34 
and cotrimoxazole37, ceftriaxone plus rifampin have 
also been used2, as well as aminoglycoside for one week 
plus rifampin and cotrimoxazole for six weeks18. in all 
our cases, the outcome was good in all mothers, includ-
ing patient 1 who suffered a relapse and underwent a 
repeat treatment course. it is interesting that in patient 
3, although sudden delivery happened during the treat-
ment with cotrimoxazole, the neonate did not manifest 
kernicterus as a possible risk if this drug is administered 
in the last week before delivery.
in conclusion, brucellosis can influence pregnancy 
outcome in spite of appropriate treatment, especially if 
brucellosis is acquired in the early stages of pregnancy. 
Thus, in endemic regions, screening for brucellosis in 
pregnant women should be performed. Brucellosis 
should be in mind in pregnant women with febrile 
symptoms and persistence of unspecific manifesta-
tions. in endemic regions, cases with unexplained 
spontaneous abortion, iufd and premature delivery 
should also be investigated for brucellosis. finally, in 
these regions, education may help prevent brucellosis 
during pregnancy.
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sažetak
BRuCeloZA u tRudnoĆi: pRiKAZi sluČAJA s RAZliČitim ishodimA  
u endemsKom podRuČJu
M. Bosilkovski, M. Stojovski, D. Siskova, A. Ridov, E. Kostoska i K. Krstevski
opisuju se različiti ishodi bruceloze u trudnoći u odnosu na fetus/novorođenče i majku. Retrospektivno su analizirani 
medicinski zapisi za pet trudnica s brucelozom. Bolesnice su liječene u nekoliko klinika za zarazne bolesti u Republici ma-
kedoniji u razdoblju od 1995. do 2009. godine. dijagnoza bruceloze temeljena je na kliničkim nalazima sukladnima s bolešću 
i potkrijepljena otkrivanjem specifičnih protutijela. ishodi trudnoće u ovih bolesnica bili su sljedeći: spontani pobačaj, intra-
uterina smrt fetusa, prijevremeni porođaj u dva slučaja (jedan s blizanačkom trudnoćom) i terminski porođaj. Recidiv je 
 nastupio kod jedne od ovih žena. Rezultati praćenja novorođenčadi pokazali su odsutnost infekcije te normalan rast i razvoj. 
Bruceloza, osobito ako je stečena u ranoj trudnoći, može utjecati na ishod trudnoće. u endemskim područjima brucelozu 
treba uvijek imati na umu kod trudnica s ustrajnom groznicom i nespecifičnim manifestacijama. u ovim područjima testira-
nje na brucelozu treba provoditi i u slučaju neobjašnjenog spontanog pobačaja, intrauterine smrti fetusa i prijevremenog 
porođaja.
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